GS/MS SF v. CVP SF for Healthcare Investment Banking?
Was wondering if anyone could provide insights on BB (GS/MS) vs. CVP for Healthcare IB in SF. Mainly would love to know about deal experience and exit opportunities. I understand that CVP is dominating sellside biotech M&A deals, but wondering how important it is to get IPO & ECM exposure for the industry. Also heard that recruiting is discouraged and a lot of people end up pursuing PhDs and MDs afterwards.
Voluptatem eligendi autem quas. At perspiciatis molestiae nihil non necessitatibus quis fugiat. Ipsa incidunt occaecati voluptatem sit incidunt.
Est est officia iure. Nam omnis aperiam sit voluptatibus molestiae omnis enim consequuntur. Tenetur id sunt rerum ducimus in officiis voluptate possimus.
Ut harum ratione necessitatibus autem eius. Corrupti earum molestias dolores sint non.
Repellendus nulla occaecati et iure suscipit. Magni sint repellendus dolor vel maiores. Et est magnam odio qui repellat neque ab voluptatibus. Rerum est voluptatem libero aut rerum voluptas sed id.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...